News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
11,325 Results
Type
Article (513)
Company Profile (1)
Press Release (10714)
Section
Business (1975)
Career Advice (12)
Deals (305)
Drug Delivery (1)
Drug Development (2603)
FDA (731)
Job Trends (493)
News (5513)
Policy (665)
Tag
Academia (27)
Accelerated approval (5)
ADA (5)
Adcomms (1)
Alliances (505)
ALS (1)
Alzheimer's disease (7)
Antibody-drug conjugate (ADC) (4)
Approvals (783)
Artificial intelligence (8)
ASCO (7)
Autoimmune disease (2)
Bankruptcy (3)
Best Places to Work (506)
Biosimilars (3)
Biotechnology (1)
Bladder cancer (16)
Breast cancer (17)
Cancer (128)
Cardiovascular disease (128)
Career advice (12)
CDC (3)
CDMO (5)
Cell therapy (23)
Clinical research (2382)
Collaboration (20)
Commercialization (1)
Company closure (1)
Compensation (3)
Complete response letters (1)
COVID-19 (141)
CRISPR (4)
C-suite (10)
Data (300)
Depression (5)
Dermatology (3)
Diabetes (37)
Diagnostics (43)
Drug discovery (4)
Drug pricing (3)
Duchenne muscular dystrophy (40)
Earnings (814)
Editorial (1)
Events (1383)
Executive appointments (6)
FDA (893)
Friedreich's ataxia (2)
Funding (11)
Gene editing (4)
Gene therapy (36)
GLP-1 (29)
Government (86)
Guidances (9)
Healthcare (177)
Hematology (2)
IgA nephropathy (1)
Immunology and inflammation (1)
Immuno-oncology (1)
Indications (10)
Infectious disease (147)
Inflammatory bowel disease (3)
Influenza (4)
Intellectual property (5)
Interviews (3)
IPO (134)
Job creations (18)
Job search strategy (10)
Kidney cancer (1)
Layoffs (2)
Legal (51)
Liver cancer (4)
Lung cancer (32)
Lymphoma (3)
Manufacturing (7)
MASH (2)
Medical device (225)
Medtech (229)
Mergers & acquisitions (173)
Metabolic disorders (51)
mRNA (11)
Multiple sclerosis (3)
Neuropsychiatric disorders (1)
Neuroscience (23)
NextGen: Class of 2026 (61)
Non-profit (30)
Now hiring (1)
Obesity (20)
Opinion (2)
Pain (8)
Pancreatic cancer (1)
Patents (13)
Patient recruitment (26)
People (433)
Phase 1 (409)
Phase 2 (757)
Phase 3 (1214)
Pipeline (280)
Policy (4)
Postmarket research (215)
Preclinical (173)
Prostate cancer (18)
Radiopharmaceuticals (4)
Rare diseases (28)
Real estate (16)
Regulatory (732)
Research institute (28)
Resumes & cover letters (3)
RSV (3)
Schizophrenia (3)
Series A (2)
Series B (3)
Spinal muscular atrophy (1)
Startups (41)
Supply chain (2)
The Weekly (1)
Vaccines (73)
Venture capital (2)
Weight loss (7)
Women's health (3)
Date
Today (4)
Last 7 days (11)
Last 30 days (47)
Last 365 days (555)
2026 (361)
2025 (571)
2024 (660)
2023 (733)
2022 (856)
2021 (854)
2020 (806)
2019 (635)
2018 (460)
2017 (519)
2016 (409)
2015 (545)
2014 (485)
2013 (427)
2012 (413)
2011 (415)
2010 (429)
Location
Africa (5)
Asia (613)
Australia (45)
California (228)
Canada (104)
China (24)
Colorado (7)
Connecticut (6)
Delaware (28)
Europe (1688)
Florida (40)
Georgia (3)
Idaho (1)
Illinois (29)
India (5)
Indiana (13)
Japan (21)
Louisiana (4)
Maryland (29)
Massachusetts (195)
Michigan (1)
Minnesota (6)
Nevada (2)
New Jersey (217)
New Mexico (1)
New York (63)
North Carolina (13)
Northern California (150)
Ohio (6)
Pennsylvania (65)
Puerto Rico (3)
South America (9)
South Carolina (3)
Southern California (63)
Tennessee (2)
Texas (39)
United States (980)
Washington State (11)
11,325 Results for "myos".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Myomo Reports Second Quarter 2026 Financial and Operating Results
August 5, 2026
·
15 min read
Press Releases
Myomo to Present at the H.C. Wainwright 28th Annual Global Investment Conference
September 2, 2026
·
1 min read
Press Releases
Myomo Reports First Quarter 2026 Financial and Operating Results
May 8, 2026
·
14 min read
Press Releases
Myomo Announces Participation in Upcoming May 2026 Investor Conferences
May 14, 2026
·
1 min read
Business
Myomo Reports First Quarter 2024 Financial Results
Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today reported financial results for the three months ended March 31, 2024.
May 8, 2024
·
14 min read
Pharm Country
MYOS CORP, Formerly Known as Myos Rens Technology, Inc., Issues Notice to its Shareholders
MYOS CORP (“MYOS” or the “Company”), is a research-based advanced nutrition company with divisions that address both Human Nutrition and Animal Health . MYOS is the sole owner of Fortetropin ® , a proprietary advanced nutrition product developed and owned by MYOS, that has been shown in multiple veterinary and human cli
December 15, 2020
·
4 min read
Gynov Uses Myo-Inositol to Combat Both Male and Female Infertility
Infertility Is a Common Struggle for Both Sexes. The Innovative French Health Brand Gynov Is Addressing This Concern with Myo-Inositol.
February 21, 2022
·
3 min read
Business
Myomo to Report Fourth Quarter Financial Results on March 7, 2024
Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”) today announced that it will report financial results for the fourth quarter and fiscal year ended December 31, 2023 on March 7, 2024.
February 29, 2024
·
2 min read
Business
Myomo to Report First Quarter Financial Results on May 8, 2024
Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced that it will report financial results for the first quarter ended March 31, 2024 on May 8, 2024.
May 1, 2024
·
2 min read
Press Releases
Myomo Reports Third Quarter 2025 Financial and Operating Results
November 10, 2025
·
16 min read
1 of 1,133
Next
